Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Gadolinium-based Contrast Agents Trigger Gadolinium Accumulation Within the Hippocampus In Vivo and Mitochondrial Alterations in Organotypic Hippocampal Tissue Cultures Ex Vivo.
AFRICTRIMS: Should exclusion of neuromyelitis optica spectrum disorder/myelin oligodendrocyte glycoprotein antibody-associated disease be a prerequisite for initiating MS disease-modifying therapy? - No.
Protocol for spatially restricted CreERT2-mediated recombination in mouse brain-infiltrating B cells using intracerebral 4-hydroxy-tamoxifen.
Therapeutic Efficacy of Mesenchymal Stem Cells at the Level of Biomarkers in Multiple Sclerosis: A Systematic Review.
Opportunistic Quambalaria fungal endophthalmitis in fumarate-treated multiple sclerosis complicated by multifocal postinfectious cerebral vasculopathy.
A Reproducible Transcriptomic Program of Neurofibroma-to-Malignant Peripheral Nerve Sheath Tumor Transformation.
AFRICTRIMS: Should exclusion of NMOSD/MOGAD be a prerequisite for initiating MS disease-modifying therapy? Yes.
AFRICTRIMS: Should exclusion of NMOSD/MOGAD be a prerequisite for initiating MS disease-modifying therapy? - Commentary.
A Scoping Review and Meta-Analysis of Proportions of Central Nervous System Manifestations Reported in Patients with Sjögren's Disease.
An Emerging Role for Oligodendrocytes and Myelin Dysfunction in Essential Tremor.
Diagnostic Utility of Novel and Established Spinal MRI Signs in AQP4-IgG-Seropositive NMOSD Myelitis.
From Lesion Length to Lesion Pattern in Neuromyelitis Optica Spectrum Disorder Myelitis: Implications for Diagnostic Criteria.
In Situ Construction of (Ni,Mn)O/MnO2 Heterostructures with Suppressed Jahn-Teller Distortion for Ultralong-Life Aqueous Zinc-Ion Batteries.
Reduced Paramagnetic Rim Visibility Signals Lesion Aging and Tissue Degeneration in Progressive Multiple Sclerosis: Impact on Clinical Trials.
Myelin sheath lengths in the central nervous system scale to axon diameter via oligodendroglial Piezo1.
Chromogranin B acts as a neuronal paracrine factor to trigger oligodendrocyte apoptosis.
Correction to "Epidemiology, Presentation, Management and Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy in Birmingham, UK: The Impact of Ethnicity".
Running out the clock: Circadian rhythm dysfunction in cognitive disease.
Guillain-Barré syndrome associated with optic neuritis following Mycoplasma pneumoniae infection.
Boundary-anchored thalamic ADC profiling shows spatially structured abnormalities in multiple sclerosis.
Pain interference and mobility in older adults with multiple sclerosis: A question of construct overlap.
Premorbid depression across levodopa equivalent daily dose-defined treatment trajectories in Parkinson's disease: A nationwide register-based cohort study.
Discriminative accuracy of the 42-point modified Mini-Balance Evaluation Systems Test for identifying Expanded Disability Status Scale-defined disability in relapsing-remitting multiple sclerosis: an exploratory diagnostic accuracy study.
Pediatric MOGAD in the Intensive Care Unit: A Case Series.
In Vivo Quantification of Myelin Injury Following Ischemic Stroke.
Pages
« first
‹ previous
…
1100
1101
1102
1103
1104
1105
1106
1107
1108
next ›
last »